SEVERE SEPSIS
Clinical trials for SEVERE SEPSIS explained in plain language.
Never miss a new study
Get alerted when new SEVERE SEPSIS trials appear
Sign up with your email to follow new studies for SEVERE SEPSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a booster shot for the immune system prevent more infections in sepsis survivors?
Disease control CompletedThis study tested a drug called GM-CSF in 166 ICU patients who had severe sepsis or septic shock and a weakened immune system. The goal was to see if the drug could reduce the number of new infections acquired in the ICU. Patients received either GM-CSF or a placebo, and research…
Matched conditions: SEVERE SEPSIS
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can less be more? study tests cutting back antibiotics in sepsis
Disease control CompletedThis study looked at whether it is safe to reduce or narrow antibiotics once doctors know which germ is causing a severe infection (sepsis). 120 intensive care patients were randomly assigned to either continue their original broad antibiotics or switch to a more targeted treatme…
Matched conditions: SEVERE SEPSIS
Phase: PHASE3 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can zinc help fight sepsis? early study explores dosing
Knowledge-focused CompletedThis early-phase study looked at how the body handles zinc in people with severe sepsis, a life-threatening infection that causes organ failure. Researchers gave different doses of intravenous zinc to 40 ICU patients on breathing machines and compared them to 15 healthy volunteer…
Matched conditions: SEVERE SEPSIS
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC